What this means
Valvular heart disease (VHD), a prevalent age-associated condition associated with high mortality, is primarily treated by prosthetic valve replacement. Bioprosthetic heart valves (BHVs) are increasingly preferred in clinical practice owing to their favorable hemodynamic performance and compatibility with transcatheter delivery.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- Not stated
- Kind of research
- A study
The science
- Original title
- Inflammation-Responsive Baicalin-Delivering Glycocalyx-Mimetic Hydrogel-Functionalized Bioprosthetic Valve for Antithrombosis and Immunomodulation.
- Authors
- Chen L, Feng Y, Huang X et al.
- Journal
- Acta biomaterialia
- Published
- Oct 16, 2026
- Study type
- Study
- PMID
- 42887585 ↗
Abstract
Valvular heart disease (VHD), a prevalent age-associated condition associated with high mortality, is primarily treated by prosthetic valve replacement. Bioprosthetic heart valves (BHVs) are increasingly preferred in clinical practice owing to their favorable hemodynamic performance and compatibility with transcatheter delivery. However, current glutaraldehyde crosslinking fails to confer antithrombotic, antioxidant, and immunomodulatory properties, leaving BHVs prone to thrombosis, oxidative stress, inflammation, and calcification, all of which accelerate structural valve deterioration (SVD) and shorten their lifespan. Herein, an inflammation-responsive, glycocalyx-mimetic hydrogel-functionalized BHV (BA@ALG-PP) was constructed using mussel-inspired catechol chemistry, which integrated a vascular glycocalyx-like layer with baicalin-loaded, reactive oxygen species (ROS)-responsive nanoparticles. With the introduction of a biocompatible glycocalyx-mimetic layer on the xenogeneic collagenous matrix, BA@ALG-PP exhibited improved antithrombotic and endothelialization performance, which was further confirmed in vivo by the rabbit intravascular implantation experiment. Moreover, the ROS-responsive nanoparticles effectively scavenged oxidative species and enabled stimulus-responsive on-demand release of anti-inflammatory molecule baicalin, thereby modulating local inflammatory responses. Transcriptional analysis of macrophages indicated that BA@ALG-PP regulated the expression of key inflammatory-related genes (Tnfaip3, Hmox1, Stat1, and Saa3) as well as suppressed pro-inflammatory signaling pathways, including NF-κB, MAPK, and JAK-STAT. Furthermore, BA@ALG-PP demonstrated improved anti-calcification property in the subcutaneous implantation experiments in rats. Collectively, this multifunctional strategy endows BHVs with synergistic antithrombotic, antioxidant, immunomodulatory, and anti-calcification capabilities, thereby offering a potential strategy for improving BHV performance that warrants further investigation in large animal models and potentially mitigating factors contributing to SVD. STATEMENT OF SIGNIFICANCE: Glutaraldehyde-crosslinked bioprosthetic heart valves (BHVs) suffer from structural valve deterioration driven by thrombosis, oxidative stress, and chronic inflammation, yet current surface engineering strategies remain functionally limited. This study reports an inflammatory-responsive glycocalyx-mimetic hydrogel functionalized BHV (BA@ALG-PP) engineered via mussel-inspired catechol chemistry. The system integrates non-glutaraldehyde crosslinking, ROS-responsive baicalin release, and endothelial glycocalyx mimicry into a multifunctional platform. BA@ALG-PP demonstrates enhanced antithrombotic performance, accelerated endothelialization, effective ROS scavenging, and macrophage polarization from M1 to M2 phenotype through NF-κB, MAPK, and JAK-STAT pathway modulation. Furthermore, it significantly reduces calcification in vivo. This work establishes a comprehensive strategy for BHV crosslinking and surface engineering, offering a clinically translatable strategy to prolong BHV durability and improve patient outcomes.
Chen L, Feng Y, Huang X et al. Inflammation-Responsive Baicalin-Delivering Glycocalyx-Mimetic Hydrogel-Functionalized Bioprosthetic Valve for Antithrombosis and Immunomodulation. Acta biomaterialia. 2026. doi:10.1016/j.actbio.2026.10.028. PMID: 42887585. https://pubmed.ncbi.nlm.nih.gov/42887585/
Related research
Home exercise may change muscle in people with kidney disease
A small trial found changes in muscle blood vessels and fewer fibrosis-linked cells after 12 weeks of home exercise. Only 25 people took part, so this does not prove the exercise caused lasting muscle benefits.
Protein NEDD4 may protect disc cells from aging and cell death in a lab test
Researchers grew disc cells in a dish with an inflammation signal. Boosting NEDD4 eased aging and cell death, and it broke down another protein called PTEN. More tests in living animals and more checks are still needed.
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.
Review of copper peptide GHK-Cu studies finds many lab results but few human trials
Researchers read 64 studies on GHK-Cu, a copper-linked peptide, and found much lab and animal work. They say well-designed human trials using microneedles are still needed.
Review of a copper peptide used in skin treatments
Researchers reviewed 20 studies on GHK-Cu, a copper peptide, for skin and beauty uses. Most were lab or animal studies, and only two were human trials, so more strong testing is still needed.
Uterine function and reproduction aging. I. Molecular and structural alterations associated with impaired decidualization in aged mouse uteri.
Reproductive aging is associated with reduced fertility and increased risk of adverse pregnancy outcomes, including miscarriage, placental dysfunction, and fetal growth restriction.
See all research on Collagen peptides →